Estimating the impact of Human papillomavirus (HPV) vaccination on HPV prevalence and cervical cancer incidence in Mali

Clinical Infectious Diseases

Volumn 52, Issue 5, 2011, Pages 641-645

  Tracy, Laree ^a   Gaff, Holly D ^c   Burgess, Colleen ^d   Sow, Samba ^a,e   Gravitt, Patti E ^b   Tracy, J Kathleen ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c OLD DOMINION UNIVERSITY   (United States)

^d MathEcology   (United States)

^e Centre pour le Developpement des Vaccins   (Mali)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; ADULT; ARTICLE; CANCER INCIDENCE; CANCER PREVENTION; CANCER RISK; CHILD; CORRELATION ANALYSIS; CULTURAL BIAS; FEMALE; HEALTH PROGRAM; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; MALI; MATHEMATICAL MODEL; OUTCOME ASSESSMENT; PAPILLOMAVIRUS INFECTION; PREVALENCE; PRIORITY JOURNAL; RISK REDUCTION; SCHOOL CHILD; UTERINE CERVIX CANCER; VACCINATION;

FEMALE; HUMANS; INCIDENCE; MALI; MODELS, THEORETICAL; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PREVALENCE; UTERINE CERVICAL NEOPLASMS; VACCINATION;

EID: 79951832979     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciq190     Document Type: Article

References (20)

1. Munoz N, Bosch FX, de Sanjose S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003;348:518-27. (Pubitemid 36159887)
2. Ferlay J, Bray F, Pisani P, Parkin DM. Globocan 2002: cancer incidence, mortality, and prevalence worldwide. Lyon, France: International Agency for Research on Cancer, 2004.
3. Biddlecom A, Bankole A, Patterson K. Vaccine for cervical cancer: reaching adolescents in sub-Saharan Africa. Lancet 2006;367:1299-300.
4. Agosti JM, Goldie SJ. Introducing HPV vaccine in developing countries-key challenges and issues. N Engl J Med 2007;356:1908-10. (Pubitemid 46740300)
5. The world factbook-mali [homepage on the Internet]. Central Intelligence Agency. Available from: https://www.cia.gov/library/publications/the-world- factbook/geos/ml.html. accessed 24 July 2007.
6. United States Agency for International Development. USAID country health statistical report, mali. Washington, DC, 2007. ORC Macro, Calverton, MD.
7. Human development report 2009. Overcoming barriers: human mobility and development [homepage on the Internet]. New York, NY: Palgrave MacMillan, 2009. Available from: http://hdr.undp.org/en/media/HDR-2009-EN-Complete.pdf.
8. Burchell AN, Richardson H, Mahmud SM, et al. Modeling the sexual transmissibility of human papillomavirus infection using stochastic computer simulation and empirical data from a cohort study of young women in Montreal, Canada. Am J Epidemiol 2006;163:534-43.
9. Goldie SJ, Grima D, Kohli M, Wright TC, Weinstein M, Franco E. A comprehensive natural history model of HPV infection and cervical cancer to estimate the clinical impact of a prophylactic HPV-16/18 vaccine. Int J Cancer 2003;106:896-904. (Pubitemid 37071668)
10. Kim JJ, Brisson M, Edmunds WJ, Goldie SJ. Modeling cervical cancer prevention in developed countries. Vaccine 2008;26(Suppl 10): K76-86.
11. Goldie SJ, Diaz M, Kim SY, Levin CE, Van Minh H, Kim JJ. Mathematical models of cervical cancer prevention in the Asia pacific region. Vaccine 2008;26(Suppl 12): M17-29.
12. Bayo S, Bosch FX, de Sanjose S, et al. Risk factors of invasive cervical cancer in Mali. Int J Epidemiol 2002;31:202-9. (Pubitemid 34284928)
13. Munoz N, Bosch FX, Shah KV, Meheus A. The Epidemiology of Human Papillomavirus and Cervical Cancer. International Agency for Research on Cancer (IARC) Scientific Publication 119. World Health Organization, Geneva, Switzerland.
14. Bosch FX, Manos MM, Munoz N, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International Biological study on Cervical Cancer (IBSCC) Study Group. J Natl Cancer Inst 1995;87:796-802.
15. Schiffman MH, Brinton LA, Devesa SS, Fraumeni JF Jr. Cancer epidemiology and prevention. In Schottenfeld D, Fraumeni JF Jr. eds: New York, NY: Oxford University Press, 1996;1090-116.
16. Hughes JP, Garnett GP, Koutsky L. The theoretical population-level impact of a prophylactic human papilloma virus vaccine. Epidemiology 2002;13:631-9. (Pubitemid 44698466)
17. Garnett GP, Anderson RM. Factors controlling the spread of HIV in heterosexual communities in developing countries: patterns of mixing between different age and sexual activity classes. Philos Trans R Soc Lond B Biol Sci 1993;342:137-59. (Pubitemid 2007851)
18. Garnett GP, Anderson RM. Contact tracing and the estimation of sexual mixing patterns: the epidemiology of gonococcal infections. Sex Transm Dis 1993;20:181-91. (Pubitemid 23213965)
19. Diaz M, Kim JJ, Albero G, et al. Health and economic impact of HPV 16 and 18 vaccination and cervical cancer screening in India. Br J Cancer 2008;99:230-8.
20. Jenkins D. A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted cervical cancer vaccine: importance of virological and clinical endpoints and implications for mass vaccination in cervical cancer prevention. Gynecol Oncol 2008;110(3 Suppl 1): S18-25.